Search research articles
Contact Us
Filters
Showing results (521-530 of 531) with videos related to
Page
of 54
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 29, 2019
Combined HIV-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestors
Sean C Patro, Leah D Brandt, Michael J Bale, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 7, 2016
NCCN Guidelines Insights: Melanoma, Version 3.2016
Daniel G Coit, John A Thompson, Alain Algazi, et al.
Nature Medicine
|
October 7, 2018
Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
David F McDermott, Mahrukh A Huseni, Michael B Atkins, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 10, 2016
Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology
Daniel G Coit, John A Thompson, Alain Algazi, et al.
Nature Medicine
|
June 6, 2018
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
David F McDermott, Mahrukh A Huseni, Michael B Atkins, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 12, 2021
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021
Susan M Swetter, John A Thompson, Mark R Albertini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 6, 2020
NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019
P Kumar Rao, Christopher Barker, Daniel G Coit, et al.
Lancet (London, England)
|
December 13, 2016
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
Arjun V Balar, Matthew D Galsky, Jonathan E Rosenberg, et al.
Plos One
|
April 7, 2021
Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial
Patricia M LoRusso, Aleksandar Sekulic, Jeffrey A Sosman, et al.
JCO Precision Oncology
|
February 15, 2019
Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma
Jan B Egan, David L Marks, Tara L Hogenson, et al.
Page
of 54
Search research articles
Search
Showing results (521-530 of 531) with videos related to
Sort By:
Page
of 54
Proceedings of the National Academy of Sciences of the United States of America
|
November 29, 2019
Combined HIV-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestors
Sean C Patro, Leah D Brandt, Michael J Bale, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 7, 2016
NCCN Guidelines Insights: Melanoma, Version 3.2016
Daniel G Coit, John A Thompson, Alain Algazi, et al.
Nature Medicine
|
October 7, 2018
Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
David F McDermott, Mahrukh A Huseni, Michael B Atkins, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 10, 2016
Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology
Daniel G Coit, John A Thompson, Alain Algazi, et al.
Nature Medicine
|
June 6, 2018
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
David F McDermott, Mahrukh A Huseni, Michael B Atkins, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 12, 2021
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021
Susan M Swetter, John A Thompson, Mark R Albertini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 6, 2020
NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019
P Kumar Rao, Christopher Barker, Daniel G Coit, et al.
Lancet (London, England)
|
December 13, 2016
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
Arjun V Balar, Matthew D Galsky, Jonathan E Rosenberg, et al.
Plos One
|
April 7, 2021
Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial
Patricia M LoRusso, Aleksandar Sekulic, Jeffrey A Sosman, et al.
JCO Precision Oncology
|
February 15, 2019
Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma
Jan B Egan, David L Marks, Tara L Hogenson, et al.
Page
of 54